Abstract
Tianeptine is a clinically used antidepressant that has drawn much attention, because this compound challenges traditional monoaminergic hypotheses of depression. It is now acknowledged that the antidepressant actions of tianeptine, together with its remarkable clinical tolerance, can be attributed to its particular neurobiological properties. The involvement of glutamate in the mechanism of action of the antidepressant tianeptine is consistent with a well-developed preclinical literature demonstrating the key function of glutamate in the mechanism of altered neuroplasticity that underlies the symptoms of depression. This article reviews the latest evidence on tianeptine's mechanism of action with a focus on the glutamatergic system, which could provide a key pathway for its antidepressant action. Converging lines of evidences demonstrate actions of tianeptine on the glutamatergic system, and therefore offer new insights into how tianeptine may be useful in the treatment of depressive disorders.
Similar content being viewed by others
References
Duman RS, Malberg J, Thome J . Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999; 46: 1181–1191.
Manji HK, Duman RS . Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 2001; 35: 5–49.
Pittenger C, Duman RS . Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008; 33: 88–109.
Duman RS, Monteggia LM . A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116–1127.
Manji HK, Gottesman II, Gould TD . Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci STKE 2003; 2003: e49.
Sheline YI . Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 2003; 54: 338–352.
Kasper S, McEwen BS . Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs 2008; 22: 15–26.
Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M et al. Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci 2007; 26: 3509–3517.
Qi H, Mailliet F, Spedding M, Rocher C, Zhang X, Delagrange P et al. Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology 2009; 56: 37–46.
Bergink V, van Megen HJ, Westenberg HG . Glutamate and anxiety. Eur Neuropsychopharmacol 2004; 14: 175–183.
Lowy MT, Wittenberg L, Yamamoto BK . Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J Neurochem 1995; 65: 268–274.
Paul IA, Skolnick P . Glutamate and depression: clinical and preclinical studies. Ann NY Acad Sci 2003; 1003: 250–272.
Sanacora G, Rothman DL, Mason G, Krystal JH . Clinical studies implementing glutamate neurotransmission in mood disorders. Ann NY Acad Sci 2003; 1003: 292–308.
Skolnick P, Legutko B, Li X, Bymaster FP . Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol Res 2001; 43: 411–423.
Zarate Jr CA, Du J, Quiroz J, Gray NA, Denicoff KD, Singh J et al. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann NY Acad Sci 2003; 1003: 273–291.
Curzon G, Kennett GA, Sarna GS, Whitton PS . The effects of tianeptine and other antidepressants on a rat model of depression. Br J Psychiatry Suppl 1992; 160: 51–55.
Thiebot MH, Martin P, Puech AJ . Animal behavioural studies in the evaluation of antidepressant drugs. Br J Psychiatry Suppl 1992; 160: 44–50.
Kelly JP, Leonard BE . The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology 1994; 33: 1011–1016.
Wagstaff AJ, Ormrod D, Spencer CM . Tianeptine: a review of its use in depressive disorders. CNS Drugs 2001; 15: 231–259.
McEwen BS, Olie JP . Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol Psychiatry 2005; 10: 525–537.
McEwen BS, Magarinos AM, Reagan LP . Structural plasticity and tianeptine: cellular and molecular targets. Eur Psychiatry 2002; 17 (Suppl 3): 318–330.
Costa e Silva JA, Ruschel SI, Caetano D, Rocha FL, da Jr SL, Arruda S et al. Placebo-controlled study of tianeptine in major depressive episodes. Neuropsychobiology 1997; 35: 24–29.
Loo H, Saiz-Ruiz J, Costa e Silva JACE, Ansseau M, Herrington R, Vaz-Serra A et al. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. J Affect Disord 1999; 56: 109–118.
Lepine JP, Altamura C, Ansseau M, Gutierrez JL, Bitter I, Lader M et al. Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study dagger. Hum Psychopharmacol 2001; 16: 219–227.
Novotny V, Faltus F . Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study. Hum Psychopharmacol 2002; 17: 299–303.
Szadoczky E, Furedi J . [Efficacy and acceptability of tianeptine and sertraline in the acute treatment phase of depression]. Encephale 2002; 28: 343–349.
Waintraub L, Septien L, Azoulay P . Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine. CNS Drugs 2002; 16: 65–75.
Nickel T, Sonntag A, Schill J, Zobel AW, Ackl N, Brunnauer A et al. Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J Clin Psychopharmacol 2003; 23: 155–168.
Olie JP, Bayle F, Kasper S . [A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression]. Encephale 2003; 29: 322–328.
Kasper S, Olie JP . A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression. Eur Psychiatry 2002; 17 (Suppl 3): 331–340.
Novotny V, Faltus F . First signs of improvement with tianeptine in the treatment of depression: an analysis of a double-blind study versus fluoxetine. Eur Neuropsychopharmacol 2003; 13 (Suppl 4): S230. Ref type: abstract.
Loo H, Deniker P . Position of tianeptine among antidepressive chemotherapies. Clin Neuropharmacol 1988; 11 (Suppl 2): S97–S102.
Guelfi JD, Pichot P, Dreyfus JF . Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology 1989; 22: 41–48.
Invernizzi G, Aguglia E, Bertolino A, Casacchia M, Ciani N, Marchesi GF et al. The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs amitriptyline. Neuropsychobiology 1994; 30: 85–93.
Brion S, Audrain S, De Bodinat C . [Major depressive episodes in patients over 70 years of age. Evaluation of the efficiency and acceptability of tianeptine and mianserin]. Presse Med 1996; 25: 461–468.
Ridout F, Hindmarch I . Effects of tianeptine and mianserin on car driving skills. Psychopharmacology (Berl) 2001; 154: 356–361.
Wilde MI, Benfield P . Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 1995; 49: 411–439.
Atmaca M, Kuloglu M, Tezcan E, Buyukbayram A . Switching to tianeptine in patients with antidepressant-induced sexual dysfunction. Hum Psychopharmacol 2003; 18: 277–280.
Bonierbale M, Lancon C, Tignol J . The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003; 19: 114–124.
Magarinos AM, Deslandes A, McEwen BS . Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999; 371: 113–122.
Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS . Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 1992; 222: 157–162.
MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003; 100: 1387–1392.
Rajkowska G . Cell pathology in mood disorders. Semin Clin Neuropsychiatry 2002; 7: 281–292.
Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001; 98: 12796–12801.
Lucassen PJ, Muller MB, Holsboer F, Bauer J, Holtrop A, Wouda J et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 2001; 158: 453–468.
Alfonso J, Frick LR, Silberman DM, Palumbo ML, Genaro AM, Frasch AC . Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol Psychiatry 2006; 59: 244–251.
Reagan LP, Hendry RM, Reznikov LR, Piroli GG, Wood GE, McEwen BS et al. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur J Pharmacol 2007; 565: 68–75.
Petrovich GD, Canteras NS, Swanson LW . Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res Brain Res Rev 2001; 38: 247–289.
Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S . Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002; 22: 6810–6818.
McEwen BS, Chattarji S . Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur Neuropsychopharmacol 2004; 14 (Suppl 5): S497–S502.
Conrad CD, LeDoux JE, Magarinos AM, McEwen BS . Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci 1999; 113: 902–913.
Wood GE, Reagan LP, Grillo CA, Piroli GG, McEwen BS . Chronic antidepressant treatment with tianeptine prevents the stress-induced potentiation of aggressive conflicts. Soc Neurosci 2003; 217: 7.
Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE . The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 2004; 55: 1171–1178.
Wood GE, Norris EH, Waters E, Stoldt JT, McEwen BS . Chronic immobilization stress alters aspects of emotionality and associative learning in the rat. Behav Neurosci 2008; 122: 282–292.
Diamond DM, Campbell A, Park CR, Vouimba RM . Preclinical research on stress, memory, and the brain in the development of pharmacotherapy for depression. Eur Neuropsychopharmacol 2004; 14 (Suppl 5): S491–S495.
Vouimba RM, Munoz C, Diamond DM . Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress 2006; 9: 29–40.
Reznikov LR, Grillo CA, Piroli GG, Pasumarthi RK, Reagan LP, Fadel J . Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment. Eur J Neurosci 2007; 25: 3109–3114.
Shakesby AC, Anwyl R, Rowan MJ . Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci 2002; 22: 3638–3644.
Whitton PS, Sarna GS, Datla KP, Curzon G . Effects of tianeptine on stress-induced behavioural deficits and 5-HT dependent behaviour. Psychopharmacology (Berl) 1991; 104: 81–85.
Rocher C, Spedding M, Munoz C, Jay TM . Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 2004; 14: 224–229.
File SE, Andrews N, al Farhan M . Anxiogenic responses of rats on withdrawal from chronic ethanol treatment: effects of tianeptine. Alcohol Alcohol 1993; 28: 281–286.
Zethof TJ, van der Heyden JA, Tolboom JT, Olivier B . Stress-induced hyperthermia as a putative anxiety model. Eur J Pharmacol 1995; 294: 125–135.
Lucassen PJ, Fuchs E, Czeh B . Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 2004; 55: 789–796.
Lucassen PJ, Vollmann-Honsdorf GK, Gleisberg M, Czeh B, De Kloet ER, Fuchs E . Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew. Eur J Neurosci 2001; 14: 161–166.
Castanon N, Bluthe RM, Dantzer R . Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology (Berl) 2001; 154: 50–60.
Castanon N, Konsman JP, Medina C, Chauvet N, Dantzer R . Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation. Psychoneuroendocrinology 2003; 28: 19–34.
Castanon N, Medina C, Mormede C, Dantzer R . Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats. Psychoneuroendocrinology 2004; 29: 778–790.
Plaisant F, Dommergues MA, Spedding M, Cecchelli R, Brillault J, Kato G et al. Neuroprotective properties of tianeptine: interactions with cytokines. Neuropharmacology 2003; 44: 801–809.
Zihl J, Gron G, Brunnauer A . Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder. Acta Psychiatr Scand 1998; 97: 351–357.
Luine V, Villegas M, Martinez C, McEwen BS . Repeated stress causes reversible impairments of spatial memory performance. Brain Res 1994; 639: 167–170.
Conrad CD, Galea LA, Kuroda Y, McEwen BS . Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 1996; 110: 1321–1334.
Jaffard R, Mocaer E, Poignant JC, Micheau J, Marighetto A, Meunier M et al. Effects of tianeptine on spontaneous alternation, simple and concurrent spatial discrimination learning and on alcohol-induced alternation deficits in mice. Behav Pharmacol 1991; 2: 37–46.
Campbell AM, Park CR, Zoladz PR, Munoz C, Fleshner M, Diamond DM . Pre-training administration of tianeptine, but not propranolol, protects hippocampus-dependent memory from being impaired by predator stress. Eur Neuropsychopharmacol 2008; 18: 87–98.
Delagrange P, Bouyer JJ, Montaron MF, Durand C, Mocaer E, Rougeul A . Action of tianeptine on focalization of attention in cat. Psychopharmacology (Berl) 1990; 102: 227–233.
Lejeune F, Poignant JC, Reure H . Electrophysiological study of tianeptine, a new enhancer of serotonin uptake with antidepressant activity. Neurophysiol Clin 1988; 18: 369–381.
Mocaer E, Rettori MC, Kamoun A . Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. Clin Neuropharmacol 1988; 11 (Suppl 2): S32–S42.
Morris RG, Kelly S, Burney D, Anthony T, Boyer PA, Spedding M . Tianeptine and its enantiomers: effects on spatial memory in rats with medial septum lesions. Neuropharmacology 2001; 41: 272–281.
Amaral DG, Kurz J . An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat. J Comp Neurol 1985; 240: 37–59.
Magarinos AM, Verdugo JM, McEwen BS . Chronic stress alters synaptic terminal structure in hippocampus. Proc Natl Acad Sci USA 1997; 94: 14002–14008.
Chamba G, Lemoine P, Flachaire E, Ferry N, Quincy C, Sassard J et al. Increased serotonin platelet uptake after tianeptine administration in depressed patients. Biol Psychiatry 1991; 30: 609–617.
Kato G, Weitsch AF . Neurochemical profile of tianeptine, a new antidepressant drug. Clin Neuropharmacol 1988; 11 (Suppl 2): S43–S50.
Rogoz Z, Skuza G, Dlaboga D, Maj J, Dziedzicka-Wasylewska M . Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system. Neuropharmacology 2001; 41: 360–368.
Invernizzi R, Pozzi L, Garattini S, Samanin R . Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism. Neuropharmacology 1992; 31: 221–227.
Kim YJ, Shin MC, Kim SA, Chung JH, Kim EH, Kim CJ . Modulation of tianeptine on ion currents induced by inhibitory neurotransmitters in acutely dissociated dorsal raphe neurons of Sprague–Dawley rats. Eur Neuropsychopharmacol 2002; 12: 417–425.
Labrid C, Mocaer E, Kamoun A . Neurochemical and pharmacological properties of tianeptine, a novel antidepressant. Br J Psychiatry Suppl 1992; 160: 56–60.
Mennini T, Mocaer E, Garattini S . Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedebergs Arch Pharmacol 1987; 336: 478–482.
Fattaccini CM, Bolanos-Jimenez F, Gozlan H, Hamon M . Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology 1990; 29: 1–8.
Watanabe Y, Sakai RR, McEwen BS, Mendelson S . Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res 1993; 615: 87–94.
Malagie I, Deslandes A, Gardier AM . Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur J Pharmacol 2000; 403: 55–65.
Pineyro G, Deveault L, de Montigny C, Blier P . Effect of prolonged administration of tianeptine on 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch Pharmacol 1995; 351: 119–125.
Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L et al. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 2005; 25: 3270–3279.
Boyer PA, Skolnick P, Fossom LH . Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study. J Mol Neurosci 1998; 10: 219–233.
Boyce-Rustay JM, Holmes A . Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 2006; 31: 2405–2414.
Ryan B, Musazzi L, Mallei A, Tardito D, Gruber SH, El Khoury A et al. Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene–environment rat model of depression. Int J Neuropsychopharmacol 2009; 12: 553–559.
Witkin JM, Marek GJ, Johnson BG, Schoepp DD . Metabotropic glutamate receptors in the control of mood disorders. CNS Neurol Disord Drug Targets 2007; 6: 87–100.
Palucha A, Pilc A . Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 2007; 115: 116–147.
Palucha A, Tatarczynska E, Branski P, Szewczyk B, Wieronska JM, Klak K et al. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology 2004; 46: 151–159.
Tatarczynska E, Palucha A, Szewczyk B, Chojnacka-Wojcik E, Wieronska J, Pilc A . Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist 36/40 (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. Pol J Pharmacol 2002; 54: 707–710.
Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, van Der PH . Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci 2003; 17: 2409–2417.
Klodzinska A, Chojnacka-Wojcik E, Palucha A, Branski P, Popik P, Pilc A . Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology 1999; 38: 1831–1839.
Karasawa J, Shimazaki T, Kawashima N, Chaki S . AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist. Brain Res 2005; 1042: 92–98.
Kawashima N, Karasawa J, Shimazaki T, Chaki S, Okuyama S, Yasuhara A et al. Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors. Neurosci Lett 2005; 378: 131–134.
Matrisciano F, Scaccianoce S, Del Bianco P, Panaccione I, Canudas AM, Battaglia G et al. Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands. J Neurochem 2005; 93: 1345–1352.
Pietraszek M, Sukhanov I, Maciejak P, Szyndler J, Gravius A, Wislowska A et al. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur J Pharmacol 2005; 514: 25–34.
Pin JP, Acher F . The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curr Drug Targets CNS Neurol Disord 2002; 1: 297–317.
Anwyl R . Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Brain Res Rev 1999; 29: 83–120.
Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P . Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 2001; 40: 1028–1033.
Li X, Witkin JM, Need AB, Skolnick P . Enhancement of antidepressant potency by a potentiator of AMPA receptors. Cell Mol Neurobiol 2003; 23: 419–430.
O’Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES . AMPA receptor potentiators for the treatment of CNS disorders. Curr Drug Targets CNS Neurol Disord 2004; 3: 181–194.
Kole MH, Swan L, Fuchs E . The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur J Neurosci 2002; 16: 807–816.
Reagan LP, Rosell DR, Wood GE, Spedding M, Munoz C, Rothstein J et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 2004; 101: 2179–2184.
Wu GY, Cline HT . Stabilization of dendritic arbor structure in vivo by CaMKII. Science 1998; 279: 222–226.
Lowy MT, Wittenberg L, Yamamoto BK . Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J Neurochem 1995; 65: 268–274.
Lowy MT, Gault L, Yamamoto BK . Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem 1993; 61: 1957–1960.
Bagley J, Moghaddam B . Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam. Neuroscience 1997; 77: 65–73.
Magarinos AM, McEwen BS . Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995; 69: 89–98.
Cameron HA, McEwen BS, Gould E . Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus. J Neurosci 1995; 15: 4687–4692.
Fuchs E, Czeh B, Kole MH, Michaelis T, Lucassen PJ . Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 2004; 14 (Suppl 5): S481–S490.
Fuchs E, Czeh B, Michaelis T, de Biurrun G, Watanabe T, Frahm J . Synaptic plasticity and tianeptine: structural regulation. Eur Psychiatry 2002; 17 (Suppl 3): 311–317.
Lynch G . AMPA receptor modulators as cognitive enhancers. Curr Opin Pharmacol 2004; 4: 4–11.
Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C et al. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J 2008; 22: 3129–3134.
Maeng S, Zarate Jr CA, Du J, Schloesser RJ, McCammon J, Chen G et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008; 63: 349–352.
Rydmark I, Wahlberg K, Ghatan PH, Modell S, Nygren A, Ingvar M et al. Neuroendocrine, cognitive and structural imaging characteristics of women on longterm sickleave with job stress-induced depression. Biol Psychiatry 2006; 60: 867–873.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McEwen, B., Chattarji, S., Diamond, D. et al. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry 15, 237–249 (2010). https://doi.org/10.1038/mp.2009.80
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2009.80
- Springer Nature Limited
Keywords
This article is cited by
-
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
Translational Psychiatry (2023)
-
Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain
Neuropsychopharmacology (2023)
-
The atypical antidepressant tianeptine confers neuroprotection against oxygen–glucose deprivation
European Archives of Psychiatry and Clinical Neuroscience (2023)
-
Mu opioid receptors on hippocampal GABAergic interneurons are critical for the antidepressant effects of tianeptine
Neuropsychopharmacology (2022)
-
Metabolomic profiling relates tianeptine effectiveness with hippocampal GABA, myo-inositol, cholesterol, and fatty acid metabolism restoration in socially isolated rats
Psychopharmacology (2022)